Podcasts about ocular

Get My Book On Amazon: https://a.co/d/avbaV48Download The Peptide Cheat Sheet: https://peptidecheatsheet.carrd.co/Download The Bioregulator Cheat Sheet: https://bioregulatorcheatsheet.carrd.co/

Dirige y presenta Juan Carlos Baruque Hernández Sumario del programa DAVID SANTISO *La verdadera historia de los dioses Anunnakis. RAÚL LÓPEZ *La visión extra ocular humana. Nuestra Web: https://mundoinsolitoradio.es Contacta: +34 687 39 80 12 - Solo WhatsApp mundoinsolitoradio@hotmail.com Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

En lo último en salud y fitness edición de abril 2025, damos un paseo por las últimas tendencias, investigaciones y noticias en el mundo de la salud y el fitness.En este episodio hablaremos de temas desde cómo la cafeína afecta tu rendimiento (y por qué a veces parece que ya no funciona), hasta la última información sobre los suplementos de omega-3 para el cuidado de tus ojos. También veremos datos nuevos sobre los monitores de glucosa que te harán repensar algunas cosas, y pondremos sobre la mesa la verdad sobre los medicamentos GLP-1 y su efecto en tu músculo.Atajos del episodio: 02:56 - ¿Tomar cafeína todos los días te vuelve inmune a sus efectos para el ejercicio?106:47 - ¿Usas lágrimas artificiales? Mejor dale a tus ojos lo que realmente necesitan211:50 - La glucosa no es tan predecible como pensabas318:16 - GLP-1 y pérdida de peso: ¿también estás perdiendo músculo?423:19 - Más omega-3 y omega-6, menos grasa corporal (sí, leíste bien: omega-6 también)5Referencias: 1.      Khodadadi, D., Azimi, F. & Moghanlou…, A. E. Habitual Caffeine Consumption and Training Status Affect the Ergogenicity of Acute Caffeine Intake on Exercise Performance. Sports … (2025).2.      Hong, S., Woo, M., Eom, Y., Kim, H. K. & Yoon…, K. C. A Multicenter, Randomized, Clinical Trial Assessing the Effect of rTG-Omega 3 Supplementation on Meibomian Gland Dysfunction Patients after Cataract Surgery rTG …. Journal of Ocular … (2025).3.      Hengist, A., Ong, J. A., McNeel, K., Guo, J. & Hall, K. D. Imprecision nutrition? Intraindividual variability of glucose responses to duplicate presented meals in adults without diabetes. The American Journal of … (2025).4.      Beavers, K. M., Cortes, T. M., Foy, C. M. & Dinkla…, L. G LP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials. … (2025).5.      Yang, Z. et al. Omega-3 and omega-6 fatty acids: Inverse association with body fat percentage and obesity risk. Nutrition Research (2025).

Send us a textWhen your pet needs ear surgery, their eyes might be the last thing on your mind. Yet Dr. Bianca Hartrum's pioneering research reveals a critical connection between ear procedures and vision health that veterinary professionals and pet owners can no longer afford to ignore.Dr. Hartrum's study examines ocular examinations before and after total ear canal ablation and bulla osteotomy (TECALBO) procedures in cats and dogs. The findings are striking: a staggering 90.9% of cats developed Horner's syndrome following surgery—far higher than previously documented rates. Additionally, 20% of patients already had eye disease related to their ear condition before surgery, while another 30% had unrelated ocular issues discovered during comprehensive exams.The research originated from a troubling case early in Dr. Hartrum's residency—a dog with a severe melting corneal ulcer and facial nerve paralysis following ear surgery. This prompted her deep dive into existing literature, where she found only passing mentions of neuro-ophthalmic complications without detailed analysis. Her study fills this critical knowledge gap with ophthalmologic expertise and data-driven recommendations that are already transforming clinical practice.The take-home message is clear and actionable: thorough eye examinations should be standard before and after ear surgeries. Dr. Hartrum recommends Schirmer tear tests, fluorescein staining, and post-operative topical lubricants as minimum protective measures. These simple steps can prevent potentially devastating vision complications. These findings can lead to new collaborative care protocols incorporating pre- and post-operative eye exams into surgical costs.Has your veterinarian discussed potential eye complications before your pet's ear surgery? Share your experience and help spread awareness about this important connection between ear and eye health in our beloved companions.JAVMA article: https://doi.org/10.2460/javma.24.08.0533INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

#297. “Turn your head and cough.” “Open wide and don't bite down." "Don't blink and don't move your head.” What makes you nervous about seeing medical professionals? Let us know that and also what YOU would have done in Kory's later-mentioned social situation. Also, there's an opportunity to unearth your darkest secrets via the LinkTree below. We want to hear what you would expect your future self to know about you for verification purposes. Kory shares a funny story of a rare opportunity with Bobby Lee, one of his favorite comedians. Did he say the right thing? Was he too creepy? Not creepy enough? Speaking of cringe, what do we think of the young folks and their new movie-going habits? Is it good for the industry? Is it more like “Not in MY theater!” in the vein of “Get off my lawn!?” We're also watching some interesting sports now that the blockbuster stuff is gone. UFC, The Masters, Formula 1, Hockey, and the like, with special mention of a beloved track-and-field athlete. Listen and enjoy! Until next time, be kind to each other.FTM Merch! - https://www.teepublic.com/user/fromthemiddleLinkTree - https://linktr.ee/fromthemidpodVOICE MAIL! Comment, ask a question, suggest topics - (614) 383-8412Artius Man - https://artiusman.com use discount code "themiddle"

Ransomware has become more difficult for organizations to defend against, but easier for adversaries to deploy. The rise of ransomware-as-a-service (RaaS) — a model in which ransomware operators write the malware and affiliates pay to launch it — has lowered the barrier to entry so threat actors of all skill levels can participate and profit.   OCULAR SPIDER is one such operator. This adversary, newly named by CrowdStrike, is associated with the development of ransomware variants including Cyclops, Knight, and RansomHub. They targeted hundreds of named victims between February 2024 and March 2025, according to CrowdStrike intelligence, and they focus on industries such as professional services, technology, healthcare, and manufacturing in regions including the United States, Canada, Brazil, and some European countries.   But OCULAR SPIDER is one of many operators in the ransomware space. Adam and Cristian take listeners back to the early days of ransomware and track its evolution, variants, and key players from the mid-2010s through the launch of RansomHub in 2024. They explain how RaaS works, why it appeals to adversaries and complicates attribution, and how defenders can prepare to face today's ransomware threats.   Come for an update on Adam's adventures in bread-making; stay for a deep-dive into the RaaS evolution and the threat actors driving it.

Alvarez Mendoza v. Bondi, No. 24-1112 (1st Cir. Mar. 31, 2025)cooperators against MS-13; Henriquez-Rivas; persecution in the U.S.; Matter of H-L-S-A-; social distinction and ocular visibility; El Salvador  United States v. Cervenak, No. 23-3466 (6th Cir. Apr. 2, 2025) (en banc) crime of violence; realistic probability test; robbery in violation of Ohio Rev. Code § 2911.02 Mathin v. Mayorkas, 746 F. Supp. 3d 1327 (M.D. Fla. Aug. 16, 2024)naturalization review; INA § 310(c); warrant of arrest; statutory interpretation; declaratory reliefSafe Passage Project:www.safepassageproject.orgSponsors and friends of the podcast!Kurzban Kurzban Tetzeli and Pratt P.A.Immigration, serious injury, and business lawyers serving clients in Florida, California, and all over the world for over 40 years.Cerenade"Leader in providing smart, secure, and intuitive cloud-based solutions"Click me!The Pen & Sword College (formerly The Clinic at Sharma-Crawford Attorneys at Law) Use Promo Code: ImmReview2025Link to Nonprofit: https://thepen-and-swordkc.org/ Link to books:https://www.rekhasharmacrawford.com/ Stafi"Remote staffing solutions for businesses of all sizes"Promo Code: STAFI2025Click me!Want to become a patron?Click here to check out our Patreon Page!CONTACT INFORMATIONEmail: kgregg@kktplaw.comFacebook: @immigrationreviewInstagram: @immigrationreviewTwitter: @immreviewAbout your hostCase notesRecent criminal-immigration article (p.18)Featured in San Diego VoyagerDISCLAIMER & CREDITSSee Eps. 1-200Support the show

This StAR episode features the CID State-of-the-Art Review on Ocular Infections.Our guest stars this episode are:Miriam Barshak (Massachusetts General Hospital; Mass Eye and Ear)Akash Gupta (University of Pittsburgh Medical Center)Journal article link: Barshak MB, Durand ML, Gupta A, Mohareb AM, Dohlman TH, Papaliodis GN. State-of-the-Art Review: Ocular Infections. Clin Infect Dis. 2024;79(5):e48-e64. doi:10.1093/cid/ciae433Journal companion article - Executive summary link: https://academic.oup.com/cid/article-abstract/79/5/1125/7906419From Clinical Infectious DiseasesEpisodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.comFebrile is produced with support from the Infectious Diseases Society of America (IDSA)

What are the real-world safety data following administration of faricimab (Vabysmo, Genentech)? Maura Di Nicola, MD, and guests Sruthi Arepalli, MD, and Barton Blackorby, MD, review data from a real-world, single-center, retrospective study of approximately 4500 injections of faricimab in over 700 patients at Wills Eye Hospital. What did the data show? And do these data effect the clinical patterns of Drs. Di Nicola, Arepalli, and Blackorby? 

A life-changing mission is underway in Saint Lucia as a team of ocular specialists provides much-needed prosthetic eye services to those in need. With treatments valued at over $55,000 USD, patients who would otherwise struggle to afford this care are receiving a new lease on life.

In this podcast, we share an update on the diagnosis and care of uveal melanoma from Ocular oncologists Dr. Lauren Dalvin and Dr. Basil Williams.   Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com Follow and reach out to us on X and IG: @mayocliniceye

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, have a conversation with Kaleb Abbott, OD, FAAO, on the importance of vitamin A in maintaining ocular surface health. Dr. Abbott discusses the various forms of vitamin A, where it can be obtained, settings in which it can be potentially harmful to the ocular surface, signs and symptoms of deficiency, and more.

Is there a way to treat liver metastasis secondary to uveal melanoma without introducing systemic, treatment-related toxicity? Dr. Altan Ahmed (interventional radiologist at Moffitt Cancer Center) and Dr. Sid Padia (interventional radiologist at UCLA) join guest-host Dr. Kavi Krishnasamy to discuss HEPZATO, a novel device-based treatment for liver metastases from uveal melanoma. --- This podcast is supported by: RADPAD® Radiation Protection https://www.radpad.com/ --- SYNPOSIS Dr. Ahmed and Dr. Padia begin by exploring the design and setup of the HEPZATO clinical trials, while also speaking on patient selection criteria. The doctors then talk through the technical aspects of the intervention. After covering workflow and considerations related to procedure timing and coordination, the doctors go on to discuss drug dosing and optimizing treatment cycles. The episode concludes with current gaps in literature, current and future research aims, and potential future applications of the HEPZATO modality in treating other malignancies such as colorectal cancer. --- TIMESTAMPS 00:00 - Introduction 05:40 - Patient Selection Criteria 09:49 - Workflow 19:17 - Procedure Timing and Coordination 29:39 - Challenges and Considerations in Drug Dosing 32:39 - Optimizing Treatment Cycles and Patient Response 37:56 - Managing Post-Treatment and Adverse Effects 43:43 - Future Research and Gaps in Current Interventions 50:45 - Exploring New Applications for PHP Therapy 55:02 - Conclusion --- RESOURCES Hepzato: https://hepzatokit.com/ FOCUS Trial - Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study: https://pubmed.ncbi.nlm.nih.gov/38704501/ FOCUS phase 3 trial results: Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases (PHP-OCM-301/301A): https://ascopubs.org/doi/pdf/10.1200/JCO.2022.40.16_suppl.9510 Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial: https://pubmed.ncbi.nlm.nih.gov/36624292/ Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma: https://pmc.ncbi.nlm.nih.gov/articles/PMC11010739/ Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC7801354/ Southampton group - Quality of life after melphalan percutaneous hepatic perfusion for patients with metastatic uveal melanoma: https://pmc.ncbi.nlm.nih.gov/articles/PMC10906212/ Leiden group - Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases: https://pubmed.ncbi.nlm.nih.gov/38587534/

This podcast episode discusses the impact of anti-glaucoma medications on ocular surface health, referencing the latest evidence-based guidelines from the American Optometric Association. It emphasizes the importance of understanding the relationship between glaucoma treatments and ocular surface disease, and the role of optometrists in managing these patients effectively. https://www.aoa.org/practice/clinical-guidelines/clinical-practice-guidelines?sso=y ---------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! questions@eyecode-education.com https://coopervision.com/our-company/news-center/press-release/coopervision-and-aoa-join-forces-launch-myopia-collective Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts  Show Sponsors: CooperVision MacuHealth EssilorLuxottica

This episode will cover practical tips for recognizing and managing eye trauma. We will look at foreign bodies and globe rupture.  Today's learning objectives: 1. Intraocular foreign body: take an effective history and select appropriate imaging depending on the type of foreign body. 2. Globe rupture: recognize that this also an ophthalmic emergency, and recognize signs that may indicate an open globe.

Join me, Danet Peterson, and special guest Karen Long as we discuss her powerful journey through ocular melanoma and the importance of self-advocacy in navigating this challenging diagnosis. From understanding the diagnosis to exploring treatments like brachytherapy and proton beam therapy, and finding support networks, this video empowers patients to take charge of their health.

In this episode of Surgery 101 where we will cover practical tips for recognizing and managing eye trauma. This week's episode will cover lacerations and compartment syndrome. For today, our objectives are: 1. Eyelid lacerations: recognize if these involve the eyelid margin or the canalicular system, and recognize why medial lid lacerations are often the most concerning. 2. Orbital compartment syndrome: recognize signs of this ophthalmic emergency and explain why a lateral canthotomy and cantholysis is the urgent procedure of choice.

In this captivating episode of How I Made It Through, hosts Kristin Taylor and Bernadette Thompson are joined by the extraordinary Lee Ann Fortunato-Heltzel for the second part of their deep dive into spiritually transformative experiences. Lee Ann, an artist who channels divine frequencies through her Meta Art, shares the profound journey of creating her latest piece, "The Frequency of Grace." This episode is not just an exploration of art but an invitation to a unique meditative experience that transcends the ordinary. Lee Ann recounts the mystical journey leading up to the creation of "The Frequency of Grace," from receiving divine guidance to being present at the total eclipse of the sun. She describes the magical unfolding of events, including the gathering of sacred waters from around the globe and collaborating with musician Davida Goodman to infuse the artwork with transformative sound. The episode culminates in an immersive meditation session, allowing listeners to engage with the frequency of grace on a deeply personal level.Join us as we explore how art, sound, and spiritual guidance converge to create a powerful tool for personal and collective healing. This episode is a testament to the divine support surrounding us and the profound impact of surrendering to our creative callings.- **[00:00] Introduction to Season 6 and Co-host Bernadette Thompson**- Kristin introduces the theme of the season and new co-host Bernadette, highlighting the journey of exploring near-death and spiritually transformative experiences.- **[03:00] Reintroduction to Lee Ann Fortunato-Heltzel**- A brief recap of the previous episode and Lee Ann's unique approach to art as a spiritual practice.- **[06:00] The Journey to Creating "The Frequency of Grace"**- Lee Ann shares the divine guidance she received to create her latest piece, emphasizing the significance of the total eclipse and the sacred water.- **[09:00] Collaboration with Musician Davida Goodman**- The serendipitous meeting with Davida and how her music became an integral part of the artwork's energy.- **[12:00] The Eclipse Experience and the Power of Community**- Lee Ann describes the profound experience of painting during the eclipse surrounded by powerful women.- **[15:00] The Role of Grace in Human Evolution**- Insights into the importance of grace as humanity navigates through challenging times.- **[18:00] Preparing for the Meditation Experience**- Instructions for listeners to engage with the meditation, focusing on the visual and auditory elements.- **[21:00] The Meditation: Embracing the Frequency of Grace**- A guided meditation accompanied by visuals and music, offering a transformative experience.- **[24:00] Post-Meditation Reflections**- Kristin and Bernadette share their personal experiences during the meditation and discuss the profound impact of Lee Ann's work.- **[27:00] The Universal Call to Creativity and Trust**- A discussion on the importance of embracing one's creative instincts and trusting the divine guidance present in everyday life. Learn more about Lee Ann Heltzel and her artwork:- Website: www.leeannheltzel.com (Shop: USE CODE ‘HOWIMADEIT20' for 20% OFF REPRODUCTION PIECES!)- The MetaArt paintings with sound (Love, Unity, Heal and Grace): www.leeannheltzel.com/galleryDIRECT LINK to purchase MetaArt: Grace: https://www.leeannheltzel.com/store/p/meta-art-grace-75ne7 (Dovita Goodman's complete music soundtrack can be accessed here as well.)

La mayoría de la población padece problemas de refracción en la vista, que son aquellos relacionados con la manera en que enfoca el ojo, como miopía, hipermetropía o astigmatismo, entre otros. El sentido de la vista es el que permite al hombre conocer el medio que lo rodea, relacionarse con sus semejantes, y el hombre debe contar con los elementos adecuados para captar e interpretar señales provenientes de aquellos. Las imágenes visuales le proporcionan a través del ojo, información sobre el color, la forma, la distancia, posición y movimiento de los objetos. El deterioro de la vista se convierte a menudo en un serio problema para las personas de edad avanzada. Si su visión está disminuyendo, considere el uso suplementario cuya función en la bioquímica y fotoquímica contribuye a una mejor visión. Ocular está científicamente diseñado para este propósito. Aporta todos los antioxidantes y bioflavonoides activos que protegen la vista. Puede obtener este Programa en LA Farmacia Natural en Los Angeles, Van Nuys, Huntington Park, El Monte, Arleta, Pico Rivera, Long Beach y en Burbank o llamando a la Línea de la Salud, al 1-800-227-8428 si desean que se lo enviemos a su casa.

CME credits: 1.00 Valid until: 17-01-2026 Claim your CME credit at https://reachmd.com/programs/cme/understanding-disease-progression-the-shift-from-ocular-to-generalized-mg/32236/ The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.

Contributor: Jorge Chalit-Hernandez, OMS3 Educational Pearls: Serotonin syndrome occurs most commonly due to the combination of monoamine oxidase inhibition with concomitant serotonergic medications like SSRIs Examples of unexpected monoamine oxidase inhibitors Linezolid - a last-line antibiotic reserved for patients with true anaphylaxis to penicillins and cephalosporins Methylene blue - not mentioned in the podcast due to its uncommon usage for methemoglobinemia Other medications that can interact with SSRIs to cause serotonin syndrome Dextromethorphan - primarily an anti-tussive at sigma opioid receptors that also has serotonin reuptake inhibition Clinical presentation of serotonin syndrome Altered mental status Autonomic dysregulation leading to hypertension (most common), hypotension, and tachycardia Hyperthermia Neuromuscular hyperactivity - tremors, myoclonus, and hyperreflexia Hunter Criteria (high sensitivity and specificity for serotonin syndrome): Spontaneous clonus Inducible clonus + agitation or diaphoresis Ocular clonus + agitation or diaphoresis Tremor + hyperreflexia Hypertonia, temperature > 38º C, and ocular or inducible clonus Management of serotonin syndrome Primarily supportive - benzodiazepines can help treat hypertension, agitation, and hyperthermia. Patients often require repeated and higher dosing of benzodiazepines Avoid antipyretics to treat hyperthermia since the elevated temperature is due to sustained muscle contraction and not central temperature dysregulation In refractory patients, cyproheptadine (a 5HT2 antagonist) may be used as a second-line treatment Patients with temperatures > 41.1º C or 106º F require medically induced paralysis and intubation to control their temperature References Boyer EW, Shannon M. The serotonin syndrome [published correction appears in N Engl J Med. 2007 Jun 7;356(23):2437] [published correction appears in N Engl J Med. 2009 Oct 22;361(17):1714]. N Engl J Med. 2005;352(11):1112-1120. doi:10.1056/NEJMra041867 Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635-642. doi:10.1093/qjmed/hcg109 Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152(6):946-951. doi:10.1038/sj.bjp.0707430 Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol (Phila). 2008;46(8):771-773. doi:10.1080/15563650701668625 Thomas CR, Rosenberg M, Blythe V, Meyer WJ 3rd. Serotonin syndrome and linezolid. J Am Acad Child Adolesc Psychiatry. 2004;43(7):790. doi:10.1097/01.chi.0000128830.13997.aa Summarized & Edited by Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/

In this episode of CUBIST, the host discusses a study titled "Utility of the Vestibular Ocular Motor Screening in Military Medicine: A Systematic Review," written by Dr. Carrie Hoppes and colleagues and published in Military Medicine online in October 2024. Dr. Hoppes, a retired Army lieutenant colonel and former director of the Army Baylor University doctoral program in physical therapy, is currently a senior research scientist and a contractor at the Geneva Foundation, and she joins the podcast to discuss her group's study. Article Citation: Hoppes, C. W., Garcia de la Huerta, T., Faull, S., Weightman, M., Stojak, M., Dibble, L., Pelo, R. M., Fino, P. C., Richard, H., Lester, M., & King, L. A. (2024). Utility of the Vestibular/Ocular Motor Screening in Military Medicine: A Systematic Review. Military medicine, usae494. Advance online publication. https://doi.org/10.1093/milmed/usae494 Article LINK: https://pubmed.ncbi.nlm.nih.gov/39432438/ CUBIST is a podcast for health care providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views and opinions of findings and or devices discussed in this podcast are those of the host, subject matter experts, and or guests. Facts represented constitute our understanding at the time of the podcast, whereas updated factual information may be developed. They should not be construed as pronouncing an official Department of Defense's position, policy, decision, or endorsement. The hosts and guests of CUBIST may be defense contract personnel who support TBICoE. The status of all hosts and guests will be identified during introductions to the podcast. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.

Victims groomed and raped by gangs have told the BBC's Senior UK Correspondent Sima Kotecha that they are adamant the crime is still happening to girls across the country. Yesterday, a Tory amendment to the government's Children's Wellbeing and Schools Bill, which wanted a national inquiry into grooming gangs, was voted down. Krupa Padhy talks to Sima and Simon Morton, a former senior investigating officer for Thames Valley Police, about what is known about how these gangs operate.Playing Nice, a new ITV drama, tells the story of two couples who discover their toddlers were accidentally swapped at birth. Actor Niamh Algar, who plays one of the mothers, and Grace Ofori-Attah, who wrote the script for the small screen, join Krupa to talk about the moral and ethical issues within the series, and why they hope it will spark a conversation.Two women who've developed a firm friendship through a shared experience of having a rare eye cancer join Krupa to talk about the incredible bond they have forged. Ocular melanoma affects only five in a million people but Tessa Wingfield-Parry and Joanna Denman, who happen to live just around the corner from each other, both were diagnosed. They talk about how they met, the impact the disease has had on their lives, and how they've discovered they've got a lot more in common than just their cancer.Whilst doing her Masters at the University of Cambridge, Times writer Tyler Bennett earnt extra money on the side writing erotica. Having cracked the code to a good steamy story, she joins Krupa along with the Man Booker shortlisted author Sarah Hall to discuss the genre, breaking taboos and erotica's ability to empower.Presenter: Krupa Padhy Producer: Rebecca Myatt

Welcome to Live From Progzilla Towers Edition 544. In this edition we heard music by Chicago, IQ, Bakelit, Annie Lennox, Ocular, I Am The Manic Whale, Giobia, Geoff Castellucci, Trans-Siberian Orchestra, Mike Mainieri, Jethro Tull, Présent, Nik Bärtsch's Ronin, Joe Satriani, Chasmhead, Big Big Train, Opeth, Les Penning & Robert Reed, Kevin Gilbert, Shakti, Sabaton, Ott, Blueneck and Trevor Horn (Ft Matt Cardle).

In this episode of CUBIST, the host discusses a study titled "Utility of the Vestibular Ocular Motor Screening in Military Medicine: A Systematic Review," written by Dr. Carrie Hoppes and colleagues and published in Military Medicine online in October 2024. Dr. Hoppes, a retired Army Lieutenant Colonel and former director of the Army Baylor University doctoral program in physical therapy, is currently a senior research scientist and a contractor at the Geneva Foundation, and she joins the podcast to discuss her group's study. Article Citation: Hoppes, C. W., Garcia de la Huerta, T., Faull, S., Weightman, M., Stojak, M., Dibble, L., Pelo, R. M., Fino, P. C., Richard, H., Lester, M., & King, L. A. (2024). Utility of the Vestibular/Ocular Motor Screening in Military Medicine: A Systematic Review. Military medicine, usae494. Advance online publication. https://doi.org/10.1093/milmed/usae494 Article LINK: https://pubmed.ncbi.nlm.nih.gov/39432438/ CUBIST is a podcast for health care providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views and opinions of findings and or devices discussed in this podcast are those of the host, subject matter experts, and or guests. Facts represented constitute our understanding at the time of the podcast, whereas updated factual information may be developed. They should not be construed as pronouncing an official Department of Defense's position, policy, decision, or endorsement. The hosts and guests of CUBIST may be defense contract personnel who support TBICoE. The status of all hosts and guests will be identified during introductions to the podcast. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.

El compositor y cantante británico reveló durante la gala de "El diablo se viste de Prada: el musical" que solo pudo escuchar el show pero no verlo debido a que perdió la vista por una infección ocular.

Lucía Prieto habla con ayuda de los mejores especialistas de Mundo Natural de cómo reforzar la salud ocular.

Dr. Rajesh Rao speaks with Dr. Jasmine H. Francis on whether sequencing of plasma-derived ctDNA can noninvasively diagnose ocular-involving histiocytosis. From her Ophthalmology Science article, “Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis.” Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis. Francis, Jasmine H. et al. Ophthalmology Science, Volume 4, Issue 5.

Welcome to another exciting episode of the Kyle and JJ Show! Today, we're diving into the cosmic adventure of Guardians of the Galaxy, gushing over those adorable creatures like Groot and Rocket, and of course, the ever-handsome Star-Lord himself, Chris Pratt! Both Kyle and JJ went in with relatively low expectations, but they've found themselves completely captivated by this universe.But before we get lost in space, there's a serious topic we need to address: eye syphilis. Don't be ashamed and risk losing an eye. Globally, there are about 12 million new cases of syphilis each year, with approximately 55,400 of them in the United States. Ocular syphilis occurs in an estimated 1% to 5% of neurosyphilis cases in the U.S. While rare, its complications are serious, potentially leading to vision loss and even blindness. The good news is that early and complete antibiotic treatment can cure ocular syphilis. So, stay informed and stay safe, just like our favorite Guardians protecting the galaxy.

Join us for a comprehensive overview of ocular trauma with vitreoretinal surgeon Dr. Ray Iezzi. We discuss how to best examine eyes after trauma, especially in the setting of vitreous hemorrhage, surgical repair options, and outcomes. Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com Follow and reach out to us on X and Instagram: @mayocliniceye

Welcome to the first installment of an exclusive 8-part ASTCT Talks series, supported by an educational grant from Sanofi US. In this series, ASTCT President Dr. Corey Cutler speaks with authors from each article in the latest ASTCT Journal of Transplantation and Cellular Therapy GVHD supplement. In this opening episode, Dr. Cutler is joined by Dr. Katie Luo, a leading ophthalmologist, to discuss the complexities of ocular GVHD, why it goes beyond “just dry eye,” and how an integrated, multidisciplinary approach can offer better patient outcomes. For further insights, read Dr. Luo's full article, “Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach”, and stay tuned as Dr. Cutler delves into each article with its author, providing a comprehensive guide on GVHD management through this entire supplement series.

"

La cirugía plástica ocular, también llamada oculoplastia, es la parte de la oftalmología que se ocupa de las estructuras faciales perioculares (párpados, órbita y vía lagrimal). En los procedimientos que se realizan en esta disciplina, la mejora estética no es el único objetivo, sino que la oculoplastia tiene una importante aplicación en la corrección de la función ocular, por ello no debe entenderse solo como una cirugía estética, sino también como una solución oftalmológica.  Algunas de las alteraciones que permite corregir la oculoplastia son las bolsas en los ojos o el exceso de piel y descolgamiento del párpado, con técnicas que seguro que te suenan, como la blefaroplastia. Su objetivo es corregir los signos y síntomas que el paso del tiempo produce en los párpados, pero también mejorar la calidad visual, ya que en algunas personas la caída del párpado superior es tan significativa que llega a limitar el campo visual.  Esta semana vamos a asistir a una masterclass en oculoplastia con la Dra. Andrea Sales, oftalmóloga de la Unidad de Oculoplastia de Clínica Baviera Madrid. Es licenciada en Medicina y Cirugía y especialista en Oftalmología con formación específica en Cirugía de párpados, órbita y vías lagrimales.  

This week, Jonathan is joined by Mandeep Sagoo, Professor of Ophthalmology and Ocular Oncology, UCL Institute of Ophthalmology, London, UK. The pair explore ocular oncology and Mandeep's groundbreaking work developing a digitally engineered 3D printed ocular prosthetic.   Use the following timestamps to navigate this episode:  (00:00)-Introduction (04:17)-Mandeep's journey into ophthalmology (08:06)-Pioneering work in Philadelphia, USA (11:15)-Lessons from the US healthcare system (13:30)-Churchill's Fellow Award (16:25)-Naevi and the role of ocular coherence tomography (20:00)-How to diagnose malignancies (30:38)-Creating prosthetic eyes following enucleation (34:06)-3D printed prosthetics (39:28)-Retinoblastoma (42:45)-Innovations in molecular medicine (44:42)-Three wishes for ocular oncology  

Siblings Ashley Engle and Brandon Birdwell discuss life, eyelash threading, (it's maybe not a thing), wild hospital occurrences and tag agency mishaps.

Listen in as they discuss the benefits of vitamins, supplementation, and lifestyle changes for preventing and slowing down many diseases, including age-related macular degeneration. Professor Nolan is a world-renowned scientist and researcher based in Waterford, Ireland where he established the Macular Pigment Research Group and founded the Nutrition Research Centre Ireland. His current research interests include the study of key nutrients for cognitive function, ocular nutrition, and brain health with a major goal of identifying ways to reduce risk of Alzheimer's disease. Topics include, but aren't limited to, carotenoids, antioxidants, lutein, zeaxanthin, meso-zeaxanthin, blue light, and macular pigment.  Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

En este episodio nos cuenta sobre las dificultades de estudiar oftalmología en cuba, regresar a monterrey, con una esposa embarazada, un colchón, 1 peso en la bolsa y muchos sueños para empezar tu práctica profesional. Hablamos sobre las oportunidades que se le presentaron el camino y como supo aprovecharlas al máximo, actualmente opera en la ciudad de monterrey utilizando la mejor tecnología, es médico de muchas celebridades y nos compartió sus mejores secretos para crear contenido y conectar con la audiencia. En el episodio se tocaron temas de salud ocular como sueros alargadores de pestañas, las mejores técnicas para desmaquillar los ojos, que hacer con el ojo rojo, como mejorar las bolsas de los ojos, que tanto afectan las pantallas a la vista, cirugía lasik y cáncer ocular, espero disfrutes este episodio tanto como yo.

In this video, Dr. Shields reveals the truth about pediatric and pregnancy ocular melanoma. Learn more about this rare form of cancer and how it can be treated. Dr. Shields reveals the truth about pediatric & pregnancy ocular melanoma in this informative video. Learn all about uveal melanoma from the expert!In this video, Dr. Shields reveals the truth about pediatric and pregnancy ocular melanoma. Learn more about this rare eye cancer.In this video, Dr. Shields reveals the truth about pediatric and pregnancy ocular melanoma. Learn more about this rare eye cancer.In this powerful episode of the Eye Believe Podcast, I'm joined by the renowned Dr. Carol Shields from Wills Eye Hospital to tackle some of the most common myths surrounding pediatric ocular melanoma and pregnancy-related ocular melanoma. Dr. Shields, an expert in ocular oncology, provides critical insights into the realities of these rare conditions and offers hope and clarity to those affected.In this episode, we cover:Myth-busting the risks of ocular melanoma in children.The truth about pregnancy and ocular melanoma: Does it increase the risk?Cutting-edge treatments for pediatric patients and expectant mothers.How early detection and genetic testing are transforming outcomes.Real-life patient stories that bring hope to families.Whether you or a loved one has been impacted by ocular melanoma or you're just looking for the facts, this conversation is a must-watch. Dr. Shields not only separates fact from fear but also shines a light on the future of treatment for children and young mothers.Don't forget to like, share, and subscribe for more episodes that dive deep into the latest in cancer research, treatments, and patient stories.

une in now to dive into Presley Jackson's incredible Polaroid project! Diagnosed at just 13, Presley has been unstoppable in sharing his journey these last few years, with the unwavering support of his amazing mom, Stephanie. His outlook in the face of #ocularmelanoma, his plaque treatment with Dr. Shields, and his transition into adulthood is nothing short of inspiring. Don't miss this video, and get ready for an exciting YouTube and Podcast channel launch later this week! A massive thank you to everyone who supports, organizes fundraisers, and participates in the Lookin' For A Cure For Ocular Melanoma 5k races! We can't achieve our goals without you, and we value every contribution! Please think about making a donation today to help ACIS continue to fund patient care, research, and educational programs like The Eye Believe Podcast. #ChildhoodCancerAwarenessMonth A special shoutout to Castle Biosciences, Inc. for sponsoring the podcast platforms!

Drs. Maura Di Nicola and Basil Williams join host Dr. Jay Sridhar to discuss the latest ongoing ocular oncology clinical trials for the treatment of uveal melanoma and associated complications of radiation therapy. Their review begins with the DRCR Retina Network's Protocol AL, which is studying the use of anti-VEGF agents or corticosteroids to reduce the occurrence of radiation retinopathy and consequent vision loss. Drs. Di Nicola and Williams also offer insights about the use of Belzupacap Sarotalocan (Bel-sar) for early-stage choroidal melanoma (CoMpass trial), as well as adjuvant treatment with darovasertib, a protein kinase C inhibitor. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Connor Thomson is a second-year law student at Villanova University Charles Widger School of Law. After graduating summa cum laude with University Honors from Saint Joseph's University's Maguire Academy of Insurance and Risk Management in 2022, he matriculated to Villanova University Charles Widger School of Law. In March 2023, at the age of twenty-three, Connor earned the Chartered Property Casualty Underwriter (CPCU) designation and began his tenure at Stickley Law, LLC, a boutique insurance defense firm that specializes in fighting fraud. In this episode of the In The Know podcast, Chris Hampshire and Connor consider what Gen-Z is looking for in the insurance industry, what compelled Connor to earn his CPCU designation at such a young age, and what the future of the insurance industry could look like.   Key Takeaways   Connor is a law student and one of the youngest CPCU designations ever. Claims is the aspect of insurance that most appeals to Connor. The value of earning a CPCU designation at an early age. The impact of internships on a successful start to the insurance industry. Volunteer work during law school has helped Connor identify his future. Connor's experience on the stage at In2Risk. Ocular disability has impacted, but not limited, Connor's determination to succeed. Writing and researching are key elements of Connor's continued education. Connor's message to Gen Z about a future in the insurance industry. A five-year look at the future of the insurance industry. Connor's advice to his early career self.   Quotes   “I didn't know much about insurance at the time, but I did a lot of research and learned that insurance is about more than selling policies.” “Claims is the perfect intersection of the law meets business.” “To me, it was an easy choice to pursue the CPCU designation at a very young age.” “There is clearly a dire need for young talent in the insurance industry.” “I think the one strategic business unit that is not getting that much attention is claims.” “The insurance industry has done a great job of investing in the next generation of insurance talent.” “When we get back together in five years, I don't think we'll be discussing this talent shortage anymore.” “There are more people today than ever before making a conscious decision to study risk management and insurance in college.”  

  "Revolutionizing Ocular Melanoma Treatment: New Insights from ASCO 2024"   "Join us at the ASCO 2024 meeting in Chicago where Castle Bioscience's groundbreaking study on Uveal melanoma is unveiled. Dive into an in-depth discussion about the latest advancements in gene expression profiling and genomic testing. Learn how these technologies are shaping the future of ocular melanoma treatment, improving patient outcomes, and guiding clinical decisions. Don't miss out on this exclusive coverage bringing hope and new solutions to melanoma patients!"  

On this episode, I was joined by Maysaa Attar, Senior Vice President of R&D at Bausch + Lomb. On this episode, Maysaa discusses: 00:00 Welcome to Episode 150! 03:00 Challenges and Innovations in Ocular Drug Delivery 09:30 Understanding Intravitreal Injections 13:26 Regulatory Considerations for Ocular Products 20:48 Innovations in Glaucoma Treatment 29:18 The Personal Impact of Vision Loss 35:40 Book Recommendations and Final Thoughts Maysaa Attar is the Senior Vice President of R&D at Bausch & Lomb, leading global pharmaceutical and consumer product research and development. She has held prominent leadership positions at Abbvie and Allergan and holds a PhD in Pharmaceutical Sciences from the University of Southern California (USC), where she also serves as a professor.

Nandini Venkateswaran, MD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, this month on To the Point to share her insights on preoperative ocular surface considerations. Dr. Venkateswaran offers her approach to optimizing the ocular surface, educating patients on the importance of properly managing dry eye, and varying her dry eye treatment strategy depending on the individual patient.

The eternal debate of freelance life vs being employed at a larger company, small teams vs big teams, bullshit jobs, self driving cars are finally discussed, Twitter VC fights, politics and tech, and Dax's list of next things to do.Want to carry on the conversation? Join us in Discord.Bullshit JobsThe Rational OptimistHere's why David Sacks, Paul Graham and other big Silicon Valley names had a brawl on X over VC behavior | TechCrunchTopics:(00:00) - What is in Adam's pocket? (00:49) - Hi. It's Adam. I'm the problem. It's Adam. (02:22) - Freelance life vs employed life (08:48) - Bullshit jobs (12:03) - Building resilience and redundancy (18:13) - Self driving vehicle hesitancy (25:30) - Dax's neighborhood won't last forever (29:29) - Where would Dax live if he had $100 million (37:50) - How self driving car tech evolved (40:24) - Ocular migraines (44:36) - Dinosaurs and weird body parts (48:58) - Dax's list of next things (51:13) - Twitter VC fights and loyalty thoughts (57:49) - Politics and tech (01:06:54) - Finishing a project let down

We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if successful in the clinic, its Neurotrophic Keratitis candidate will vastly improve the patient experience. It will also prove unequivocally that there's biotech business value in front-of-the-eye therapeutics, as opposed to just parenterally-administered back-of-the-eye biologics. On this episode of the Business of Biotech podcast, Atwell shares the stories of his career focus on the cornea, Claris' founding and funding progress, and why there's big, multi-indication opportunity for the company's novel HGF therapeutics in corneal diseases.Register for Bioprocess Online's Bio Expo Live, being held July 30th through August 1st . This inaugural expo is a fantastic opportunity for biopharma companies and contract manufacturers to evaluate the latest and greatest from the comfort of your desktop or mobile device. Conveniently, we've broken down the lineup into Upstream Solutions July 30th, Downstream Solutions July 31st, and Quality, Analytical, and Data Solutions August 1st. It's absolutely free to register for this series of short, digestible, and interactive sessions -- just hit the links above to register for Bio Expo Live today!